Oncologix Financial Statements From 2010 to 2024
| OCLG Stock | USD 0.0001 0.00 0.00% |
Check Oncologix Tech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncologix Tech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oncologix financial statements analysis is a perfect complement when working with Oncologix Tech Valuation or Volatility modules.
Oncologix |
Oncologix Tech Company Return On Asset Analysis
Oncologix Tech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Oncologix Tech Return On Asset | -0.12 |
Most of Oncologix Tech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncologix Tech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Oncologix Tech has a Return On Asset of -0.1183. This is 74.83% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 15.5% lower than that of the firm.
Oncologix Tech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oncologix Tech's current stock value. Our valuation model uses many indicators to compare Oncologix Tech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncologix Tech competition to find correlations between indicators driving Oncologix Tech's intrinsic value. More Info.Oncologix Tech is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncologix Tech's earnings, one of the primary drivers of an investment's value.About Oncologix Tech Financial Statements
Oncologix Tech stakeholders use historical fundamental indicators, such as Oncologix Tech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oncologix Tech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oncologix Tech's assets and liabilities are reflected in the revenues and expenses on Oncologix Tech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oncologix Tech. Please read more on our technical analysis and fundamental analysis pages.
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Oncologix Pink Sheet
Oncologix Tech financial ratios help investors to determine whether Oncologix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncologix with respect to the benefits of owning Oncologix Tech security.